High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Anne M. R. Schrader; Patty M. Jansen; Rein Willemze; Maarten H. Vermeer; Anne-Marie Cleton-Jansen; Sebastiaan F. Somers; Hendrik Veelken; Ronald van Eijk; Willem Kraan; Marie Jose Kersten; Michiel van den Brand; Wendy B. C. Stevens; Daphne de Jong; Myrurgia Abdul Hamid; Bea C. Tanis; Eduardus F. M. Posthuma; Marcel Nijland; Arjan Diepstra; Steven T. Pals; Arjen H. G. Cleven; Joost S. P. Vermaat

doi:10.1182/blood-2017-12-822817

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Anne M. R. Schrader, Patty M. Jansen, Rein Willemze, Maarten H. Vermeer, Anne-Marie Cleton-Jansen, Sebastiaan F. Somers, Hendrik Veelken, Ronald van Eijk, Willem Kraan, Marie Jose Kersten, Michiel van den Brand, Wendy B. C. Stevens, Daphne de Jong, Myrurgia Abdul Hamid, Bea C. Tanis, Eduardus F. M. Posthuma, Marcel Nijland, Arjan Diepstra, Steven T. Pals, Arjen H. G. ClevenJoost S. P. Vermaat^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	2086-2089
Number of pages	4
Journal	Blood
Volume	131
Issue number	18
DOIs	https://doi.org/10.1182/blood-2017-12-822817
Publication status	Published - 3 May 2018

Keywords

CLINICAL PRESENTATION
TRANSLOCATION
CHEMOTHERAPY
FREQUENCY
RITUXIMAB
IBRUTINIB
ORIGIN
DNA

Access to Document

10.1182/blood-2017-12-822817

Cite this

Schrader, A. M. R., Jansen, P. M., Willemze, R., Vermeer, M. H., Cleton-Jansen, A.-M., Somers, S. F., Veelken, H., van Eijk, R., Kraan, W., Kersten, M. J., van den Brand, M., Stevens, W. B. C., de Jong, D., Hamid, M. A., Tanis, B. C., Posthuma, E. F. M., Nijland, M., Diepstra, A., Pals, S. T., ... Vermaat, J. S. P. (2018). High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma. Blood, 131(18), 2086-2089. https://doi.org/10.1182/blood-2017-12-822817

@article{dbfb5206a9094e0ba6fdc3062f93e41c,

title = "High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma",

keywords = "CLINICAL PRESENTATION, TRANSLOCATION, CHEMOTHERAPY, FREQUENCY, RITUXIMAB, IBRUTINIB, ORIGIN, DNA",

author = "Schrader, {Anne M. R.} and Jansen, {Patty M.} and Rein Willemze and Vermeer, {Maarten H.} and Anne-Marie Cleton-Jansen and Somers, {Sebastiaan F.} and Hendrik Veelken and {van Eijk}, Ronald and Willem Kraan and Kersten, {Marie Jose} and {van den Brand}, Michiel and Stevens, {Wendy B. C.} and {de Jong}, Daphne and Hamid, {Myrurgia Abdul} and Tanis, {Bea C.} and Posthuma, {Eduardus F. M.} and Marcel Nijland and Arjan Diepstra and Pals, {Steven T.} and Cleven, {Arjen H. G.} and Vermaat, {Joost S. P.}",

year = "2018",

month = may,

day = "3",

doi = "10.1182/blood-2017-12-822817",

language = "English",

volume = "131",

pages = "2086--2089",

journal = "Blood",

issn = "0006-4971",

publisher = "The American Society of Hematology",

number = "18",

}

Schrader, AMR, Jansen, PM, Willemze, R, Vermeer, MH, Cleton-Jansen, A-M, Somers, SF, Veelken, H, van Eijk, R, Kraan, W, Kersten, MJ, van den Brand, M, Stevens, WBC, de Jong, D, Hamid, MA, Tanis, BC, Posthuma, EFM, Nijland, M, Diepstra, A, Pals, ST, Cleven, AHG & Vermaat, JSP 2018, 'High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma', Blood, vol. 131, no. 18, pp. 2086-2089. https://doi.org/10.1182/blood-2017-12-822817

TY - JOUR

T1 - High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

AU - Schrader, Anne M. R.

AU - Jansen, Patty M.

AU - Willemze, Rein

AU - Vermeer, Maarten H.

AU - Cleton-Jansen, Anne-Marie

AU - Somers, Sebastiaan F.

AU - Veelken, Hendrik

AU - van Eijk, Ronald

AU - Kraan, Willem

AU - Kersten, Marie Jose

AU - van den Brand, Michiel

AU - Stevens, Wendy B. C.

AU - de Jong, Daphne

AU - Hamid, Myrurgia Abdul

AU - Tanis, Bea C.

AU - Posthuma, Eduardus F. M.

AU - Nijland, Marcel

AU - Diepstra, Arjan

AU - Pals, Steven T.

AU - Cleven, Arjen H. G.

AU - Vermaat, Joost S. P.

PY - 2018/5/3

Y1 - 2018/5/3

KW - CLINICAL PRESENTATION

KW - TRANSLOCATION

KW - CHEMOTHERAPY

KW - FREQUENCY

KW - RITUXIMAB

KW - IBRUTINIB

KW - ORIGIN

KW - DNA

U2 - 10.1182/blood-2017-12-822817

DO - 10.1182/blood-2017-12-822817

M3 - Comment/Letter to the editor

C2 - 29514783

SN - 0006-4971

VL - 131

SP - 2086

EP - 2089

JO - Blood

JF - Blood

IS - 18

ER -